BMS-025

• Target:

  STING

• Related Pathways:

  Immunology/Inflammation

• Bioactivity:

  BMS-025 is an orthogonal STING agonist that can induce chemical shifts in the STINGM271 residue, thereby further activating STINGIFN signal transduction. BMS-025 is applicable in the study of monogenic autoinflammatory diseases such as SAVI.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C